Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle, The European List of Key Medicines for Medical Education: A Modified Delphi Study, «CLINICAL PHARMACOLOGY & THERAPEUTICS», 2024, 115, pp. 515 - 524 [Scientific article]Open Access
Masetti, R.; Bossu, G.; Muratore, E.; Leardini, D.; Gatti, M.; Di Sario, R.; Pea, F.; Esposito, S., Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine, «PAEDIATRIC DRUGS», 2024, 27, pp. 41 - 56 [Scientific article]
Gatti, Milo; Viale, Pierluigi; Pea, Federico, Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 79, pp. 195 - 199 [Scientific article]
Bianco, Gabriele; Boattini, Matteo; Cricca, Monica; Diella, Lucia; Gatti, Milo; Rossi, Luca; Bartoletti, Michele; Sambri, Vittorio; Signoretto, Caterina; Fonnesu, Rossella; Comini, Sara; Gaibani, Paolo, Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol, «CURRENT ISSUES IN MOLECULAR BIOLOGY», 2024, 46, pp. 14132 - 14153 [Scientific article]Open Access
Gatti, Milo; Viale, Pierluigi; Cojutti, Pier Giorgio; Zamparini, Eleonora; De Paolis, Massimiliano; Giannella, Maddalena; Pea, Federico; Tedeschi, Sara, A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, Article number: 106773 , pp. 1 - 8 [Scientific article]Open Access
Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F., A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF), «JOURNAL OF CRITICAL CARE», 2023, 76, Article number: 154301 , pp. 1 - 6 [Scientific article]Open Access
Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, pp. 1 - 7 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 62, Article number: 106992 , pp. 1 - 3 [Scientific article]
Gatti, Milo; Tam, Vincent H; Gaibani, Paolo; Cojutti, Pier Giorgio; Viale, Pierluigi; Pea, Federico, A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, Article number: 106760 , pp. 1 - 3 [Scientific article]Open Access
Di Bella S.; Gatti M.; Principe L., Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?, «EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES», 2023, 42, pp. 917 - 918 [Scientific article]
Gatti, Milo; Fornaro, Giacomo; Viale, Pierluigi; Pea, Federico; Giannella, Maddalena, Clinical efficacy of renal dosing adjustments of ceftazidime‐avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: a systematic review and meta‐analysis of observational studies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 617 - 629 [Scientific article]
Gatti, Milo; Pea, Federico, Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2023, 78, pp. 1556 - 1557 [Comment or similar]
Gatti, Milo; Rinaldi, Matteo; Bonazzetti, Cecilia; Gaibani, Paolo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2023, 67, Article number: e0096923 , pp. 1 - 12 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia?, «ANTIBIOTICS», 2023, 12, Article number: 1736 , pp. 1 - 10 [Scientific article]Open Access
Gatti, Milo; Rinaldi, Matteo; Potena, Luciano; Salvaterra, Elena; Morelli, Maria Cristina; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?, «TRANSPLANT INFECTIOUS DISEASE», 2023, -, Article number: e14107 , pp. 1 - 8 [Scientific article]Open Access
